Statement of Variation or Deviation for funds raised through Rights Issue for the quarter ended June 30, 2026.
Statement of no deviation or variation in utilisation of Rights Issue proceeds for quarter ended June 30, 2026 (Rs 424.68 Cr raised on Mar 27, 2026). Funds used as per original objects: Rs 170 Cr for loan repayment, Rs 154.04 Cr for acquisition, Rs 95.83 Cr for corporate purposes, Rs 4.81 Cr for issue expenses. Minor reallocation within corporate purposes noted, no overall deviation. Audit Committee reviewed with no comments.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 HCG — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add HCG to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Healthcare Global Enterprises Limited
Important.
The summary above is generated automatically from Healthcare Global Enterprises Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.